Pharmacists in Attica, IN Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Natalie Bowman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Jackson St, Attica, IN 47918 Phone: 765-762-3390 |
 Dr. Jacob Gray Leclaire, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Jackson St, Attica, IN 47918 Phone: 317-431-7757 |
Megan Munson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Jackson St, Attica, IN 47918 Phone: 765-762-3390 |
News Archive
Researchers discover ingredient vital for blood vessel formation
Researchers at the University of Virginia School of Medicine have discovered an ingredient vital for proper blood vessel formation that explains why numerous promising treatments have failed.
Child psychiatrist available on call to help assess separated immigrant children
Child psychiatrist Matthew Biel, MD, MSc, wasn't at all surprised to learn from news reports in early July that two children separated at the US border from their Central American parents and sent to Connecticut were diagnosed, by a Yale University psychiatrist, with "full blown acute post traumatic stress disorder."
Some parents may underestimate drowning risks of children, new poll suggests
As kids get ready to splash around in pools this summer, some parents may underestimate drowning risks, suggests a new national poll.
Researchers develop one-step analysis for detecting tumor markers in blood
Benign growth, or cancer? Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously - involving highly specific proteins. An increased concentration in the blood provides one indication of the disease for physicians. However, it has been quite expensive in time and effort to detect the markers thus far. This is because all kinds of molecules and proteins are teeming in the blood. To be able to detect a single specific one, doctors must first separate and purify the blood in several steps, and then isolate the marker they are searching for from the rest of the molecules.
Ferring Pharmaceuticals launches new trial of Degarelix for intermittent androgen deprivation therapy
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
› Verified 8 days ago